Additionally, we identify a core group of genes that are concomitantly m6A hypermethylated and transcriptionally upregulated upon SETD2 inactivation, which are enriched in pathways known to promote metabolic reprogramming in SETD2 deficient ccRCC [30]. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.